Payments for Licensed Products. (a) With respect to Net Sales of all Licensed Products: As further consideration for CTI’s grant of the rights to TGTX hereunder, TGTX shall pay to CTI a royalty of on aggregate annual worldwide Net Sales of all such Licensed Products by TGTX and its Affiliates and Sublicensees (but excluding Net Sales of a given Licensed Product after its applicable Royalty Term) at the percentage rates set forth below: Annual Worldwide Net Sales of All Licensed Products per Calendar Year (US Dollars) Incremental Royalty Rate For Net Sales of such Licensed Products from $0 up to and including $* *% For that portion of Net Sales of such Licensed Products that is greater than $* *%
Appears in 3 contracts
Samples: Collaboration Agreement (Checkpoint Therapeutics, Inc.), Collaboration Agreement (Checkpoint Therapeutics, Inc.), Collaboration Agreement (Tg Therapeutics, Inc.)
Payments for Licensed Products. (a) With respect to Net Sales of all Licensed Products: As further consideration for CTI’s grant of the rights to TGTX hereunder, TGTX shall pay to CTI a royalty of on aggregate annual worldwide Net Sales of all such Licensed Products by TGTX and its Affiliates and Sublicensees (but excluding Net Sales of a given Licensed Product after its applicable Royalty Term) at the percentage rates set forth below: Annual Worldwide Net Sales of All Licensed Products per Calendar Year (US Dollars) Incremental Royalty Rate For Net Sales of such Licensed Products from $0 up to and including $[ * *] [ * ]% For that portion of Net Sales of such Licensed Products that is greater than $[ * *] [ * ]%
Appears in 2 contracts
Samples: Collaboration Agreement (Tg Therapeutics, Inc.), Collaboration Agreement (Checkpoint Therapeutics, Inc.)
